Issued Patents All Time
Showing 1–25 of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12285482 | Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS2, and/or S-HBsAg regions of the HBV envelope protein | Edward Clark, Deborah Fuller, Michael Gale | 2025-04-29 |
| 11883488 | Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen | Edward Clark, Deborah Fuller, Amanda MAK | 2024-01-30 |
| 11607460 | Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathway | Timothy S. Lewis, Julie McEarchern | 2023-03-21 |
| 11389532 | Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope protein | Edward Clark, Deborah Fuller, Michael Gale | 2022-07-19 |
| 11351269 | Anti-NTB-A antibodies and related compositions and methods | Timothy S. Lewis, Lori Westendorf, Django Sussman | 2022-06-07 |
| 11324819 | Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen | Edward Clark, Deborah Fuller, Amanda MAK | 2022-05-10 |
| 11213584 | Dosage and administration of non-fucosylated anti-CD40 antibodies | Shyra Gardai, Stanford Peng, Jing Yang, Haley Neff-LaFord | 2022-01-04 |
| 11202827 | Dosage and administration of non-fucosylated anti-CD40 antibodies | Shyra Gardai, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas Manley | 2021-12-21 |
| 10435468 | Anti-NTB-A antibodies and related compositions and methods | Timothy S. Lewis | 2019-10-08 |
| 10201615 | Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathway | Timothy S. Lewis, Julie McEarchern | 2019-02-12 |
| 9708404 | Anti-NTB-A antibodies and related compositions and methods | Timothy S. Lewis | 2017-07-18 |
| 9345785 | Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates | Alan F. Wahl, Nathalie Scholler, Linda A. Pestano | 2016-05-24 |
| 9272052 | Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathway | Timothy S. Lewis, Julie McEarchern | 2016-03-01 |
| 9051372 | Anti-CD70 antibody and its use for the treatment of cancer and immune disorders | Julie McEarchern, Alan F. Wahl | 2015-06-09 |
| 8663642 | Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders | Julie McEarchern, Jonathan G. Drachman | 2014-03-04 |
| 8647624 | Treatment of immune disorders with anti-CD70 antibody | Julie McEarchern, Alan F. Wahl | 2014-02-11 |
| 8609104 | Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates | Alan F. Wahl, Nathalie Scholler, Linda A. Pestano | 2013-12-17 |
| 8562987 | Humanized anti-CD70 binding agents and uses thereof | Charlotte McDonagh, Paul Carter, Julie McEarchern | 2013-10-22 |
| 8337838 | Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders | Julie McEarchern, Alan F. Wahl | 2012-12-25 |
| 8067546 | Humanized anti-CD70 binding agents and uses thereof | Charlotte McDonagh, Paul Carter, Julie McEarchern | 2011-11-29 |
| 7662387 | Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders | Alan F. Wahl, Nathalie Scholler, Linda A. Pestano | 2010-02-16 |
| 7641903 | Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders | Julie McEarchern, Alan F. Wahl | 2010-01-05 |
| 7572631 | Activation and expansion of T cells | Ronald J. Berenson, Mark Bonyhadi, Zahbea Saund, Stewart Craig, Alan Hardwick +3 more | 2009-08-11 |
| 7541184 | Activation and expansion of cells | Ronald J. Berenson, Mark Bonyhadi, Narinder Saund, Stewart Craig, Alan Hardwick +3 more | 2009-06-02 |
| 7491390 | Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders | Julie McEarchern, Alan F. Wahl | 2009-02-17 |